Wai Chun Bio-Technology Limited (0660.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 33.55M |
| Enterprise Value | 166.29M |
| P/E Ratio | -10.34 |
| PEG Ratio | -0.23 |
| Price/Sales Ratio | 0.27 |
| Price/Book Ratio | -1.12 |
| Enterprise/Revenue | 0.5 |
| Enterprise/EBITDA | 19.74 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -0.01 |
| Operating Margin | 0.01 |
AD
Management Effectiveness
| Return On Assets | -0.03 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 568.26M |
| Revenue/Share | 3.18 |
| Gross Profit | 50.53M |
| EBITDA | 13.82M |
| Net Income | -6.9M |
| Diluted EPS | -0.04 |
Balance Sheet
| Total Cash | 5.61M |
| Total Cash/Share | 0.03 |
| Total Debt | 138.35M |
| Total Debt/Equity | -2.17 |
| Current Ratio | 0.67 |
| Book Value Per Share | -0.19 |
Price History
| 52-Week Change | 84.33 |
| 52-Week High | 2.33 |
| 52-Week Low | 0.15 |
| Moving Average 50 Days | 0.46 |
| Moving Average 200 Days | 0.4 |
Statistics
| Average Volume | 157,279 |
| Shares Outstanding | 384.31M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 14, 2023 |
AD
